Income statement, balance sheet and cash flow statement for the last 3 fiscal years, taken from the XBRL data Yuanbao Inc. files with the SEC in its annual reports.
In CNY millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2023
FY2025
FY2025
Revenue
2,045
3,285
4,373
Cost of revenue
138
166
167
Gross profit
1,907
3,118
4,206
Research and development
129
231
365
Selling and marketing
1,462
1,790
2,217
General and administrative
142
239
287
Other non-operating income
8.93
1.76
9.09
Pre-tax income
205
891
1,409
Income tax
0.29
25.6
101
Income from continuing operations
205
866
1,308
Net income
203
866
1,308
EPS, basic
-4.71
4.34
9.29
EPS, diluted
-4.71
3.19
4.57
Shares, basic (weighted)
70.7
100
216
Shares, diluted (weighted)
70.7
271
286
Balance sheet
FY2023
FY2025
FY2025
Cash and equivalents
863
1,905
860
Short-term investments
336
2,829
Receivables
261
441
Other current assets
1.77
0.63
Total current assets
2,673
4,458
Property, plant and equipment
4.9
13.8
Lease right-of-use assets
19.3
8.57
Intangible assets
58
64.6
Other non-current assets
17.6
24.8
Total assets
2,780
4,656
Accounts payable
10.7
17.4
Accrued liabilities
161
230
Deferred revenue
118
63.5
Total current liabilities
941
1,139
Lease liabilities
5.71
0.85
Total liabilities
993
1,309
Paid-in capital
199
3,180
Retained earnings
-1,932
-72.9
Other comprehensive income
18.6
9.32
Shareholders' equity
-2,137
-1,634
3,346
Total equity
-2,137
-1,634
3,346
Total liabilities and equity
2,780
4,656
Shares outstanding
107
Cash flow statement
FY2023
FY2025
FY2025
Net income
203
866
1,308
Stock-based compensation
37.1
64
74.3
Deferred income tax
0.02
24.7
97.1
Change in receivables
-20.4
-16.2
-179
Cash from operations
442
1,208
1,495
Capital expenditures
-4.64
-3.34
-19
Cash from investing
-45.3
-158
-2,723
Stock issued
18
0.03
Cash from financing
18
-9.11
197
Net change in cash
421
1,046
-1,036
Free cash flow
437
1,204
1,476
Income taxes paid
2
0.6
0.66
Key metrics
Worked out from the statements above. Latest values use fiscal 2025. No valuation: the share price is quoted in a different currency than the statements.
Profitability
Metric
Value
How it is calculated
Gross margin
96.2%
Gross profit / revenue.
Pre-tax margin
32.2%
Pre-tax income / revenue.
Net margin
29.9%
Net income / revenue.
FCF margin
33.8%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
34.2%
Cash from operations / revenue.
Effective tax rate
7.2%
Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)
152.7%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
35.2%
Net income / average total assets.
R&D / revenue
8.3%
Research and development expense / revenue.
Stock-based pay / revenue
1.7%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
0.4%
Capital expenditures / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
33.1%
Revenue vs the same period a year earlier. Only from a positive base.
Gross profit growth, 1y
34.9%
Gross profit vs the same period a year earlier. Only from a positive base.
Net income growth, 1y
51.0%
Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y
43.3%
EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y
23.8%
Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y
22.6%
Free cash flow vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
67.5%
Total assets vs the same period a year earlier. Only from a positive base.
Share count change, 1y
5.4%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
3.91x
Current assets / current liabilities.
Quick ratio
3.63x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
3.24x
(Cash + short-term investments) / current liabilities.
Free cash flow / net income, when net income is positive.
Capex / operating cash flow
1.3%
Capital expenditures / cash from operations, when that is positive.
Per share
Metric
Value
How it is calculated
EPS, diluted
CN¥4.57
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic
CN¥9.29
Net income per basic share, as reported (split-adjusted).
Revenue per share
CN¥15.30
Revenue / diluted weighted shares.
FCF per share
CN¥5.16
Free cash flow / diluted weighted shares.
Operating cash flow per share
CN¥5.23
Cash from operations / diluted weighted shares.
Book value per share
CN¥11.70
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Yuanbao Inc. reported revenue of CN¥4.37B for fiscal 2025, 33.1% higher than the year before.
Was Yuanbao Inc. profitable in fiscal 2025?
Yes. Net income was CN¥1.31B, a net margin of 29.9%.
How much free cash flow did Yuanbao Inc. generate in fiscal 2025?
Cash from operations of CN¥1.50B minus capital expenditures of CN¥19.0M left free cash flow of CN¥1.48B.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.